Aptadel Therapeutics
PrivateLast Round
VC Round
Mar 24, 2026
Total Funding Raised
$2.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aptadel Therapeutics is a drug discovery company developing an RNA-based platform of targeted therapy to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptadel Therapeutics Comparables
Compare Aptadel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TME Pharma N.V. | 67% | |
| Aptamer Sciences Inc | 66% | |
| aptaTargets | 60% | |
Aptadel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2026 | ||||
| Grant | Feb 11, 2025 | ||||
| Seed | Jan 21, 2021 |
Aptadel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newsight Tech Angels | VC Round |
| Little Warrior Foundation | VC Round, Grant |
| Fundación Alba Pérez | Seed |
| Chasing Science | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 43% MoM.
- Apr 22, 2026
Monthly visitors increased 180% MoM, reaching 829.
Aptadel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aptadel Therapeutics's valuation, stock price, and market status.